Skip to main content
  • English
  • Español
Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
      • Share Performance
      • Shares and Capital Structure
      • Dividends
      • Share Issues
      • Takeover Bids
      • Shareholdings
    • Financial Information
      • Financial Results and Accounts
      • Public Periodic Information
      • Average supplier payment period
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
      • General Shareholders Meeting
      • Board of Directors
      • Board Committees
      • Shareholder Agreements
      • Annual Corporate Governance Reports
      • Annual Director Remuneration Reports
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us

Breadcrumb

  1. Home
6-15 November 2023

BIO-Europe 2023

Trade Fair Center Messe München

Munich

Germany

6 November 2023

ORYZON to provide corporate progress updates at several events in November

27 October 2023

ORYZON reports financial results and corporate updates for quarter ended September 30, 2023

10 October 2023

ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder

3 October 2023

ORYZON receives two grants to further explore the role of epigenetic targets in the treatment of neuronal pathologies

20-24 October 2023

ESMO (European Society for Medical Oncology) 2023 congress

Madrid

Spain

12 October 2023

Roth Capital Partners 2nd Healthcare Opportunities Conference

The Yale Club, New York City

NY

United States

11-12 October 2023

Jefferies Inaugural Biotech CNS/Neuro Summit

Jefferies Conference Center, New York City

NY

United States

9-10 October 2023

Investor Access 2023 Event

Salons Hoche

Paris

France

7-10 October 2023

36th European College of Neuropsychopharmacology congress (ECNP 2023)

Centre Convencions Internacional de Barcelona (CCIB)

Barcelona

Spain

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Next page Next ›
  • Last page Last »
Subscribe to
Logo Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
    • Financial Information
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us
  • © Oryzon Genomics, S.A. - All Rights Reserved

    • Legal
    • Privacy Policy
    • Cookie Policy
    • Ethics Channel